CAS: 56545-22-3; (S)-Methyl 2-Aminobutanoate Hydrochloride

相似化合物

85774-09-0 7682-18-0 15399-22-1

上下游产品

methanol L-2-aminobutyric acid (S)-2-amino-but-3-enoic acid methyl ester hydr°Chloride methyl 2-[(diphenylphosphoryl)amino]butanoateBenzyloxycarbonyl-L-β-amino-β-phenyl-propionyl-L-α-amino-buttersaeuremethylester 3B°C-Tyr-Abu-°CH3 L-methyl 2-aminobutyrate L-(phenylsulfonyl)proline amide L-Abu-NHMe

📜乙烯基甘氨酸甲酯盐酸盐置于pd-Baso4 氢气体系中,用 甲醇 作为反应溶剂,化学反应 4.0H,反应生成 (2S)-2-氨基丁酸甲酯盐酸盐
参考文献:L-Vinylglycine
标题:L-Vinylglycine
摘要:
DOI:10.1021/jo01312A002

专利信息

专利号:US-2012282180-A1
优先权日:2011-05-06
标题 :Compounds with Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof
发明人：KOLB HARTMUTH C; HAUFE GUENTER; BEHRENDS MALTE; KOPKA KLAUS; WAGNER STEFAN; HUGENBERG VERENA; BREYHOLZ HANS-JOERG; HERMANN SVEN; SCHAEFERS MICHAEL
权利人:KOLB HARTMUTH C; HAUFE GUENTER; BEHRENDS MALTE; KOPKA KLAUS; WAGNER STEFAN; HUGENBERG VERENA; BREYHOLZ HANS-JOERG; HERMANN SVEN; SCHAEFERS MICHAEL
摘要:The present invention relates to the field of therapeutic and diagnostic agents and more specifically to compounds of formula (I) that are inhibitors of matrix-metalloproteinases (MMPs) and are useful in the treatment of diseases related thereto such as cardiovascular diseases, inflammatory diseases and malignant diseases. One embodiment of the invention is a compound of formula (I) labeled with a 18-fluorine atom having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the inhibitors of matrix-metalloproteinases (MMPs) of the invention or the corresponding labeled compounds useful as diagnostic imaging agents of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the inhibitors of matrix-metalloproteinases (MMPs) of the invention and of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention.

专利号:US-12221413-B2
优先权日:2015-05-25
标 题:Processes to produce brivaracetam
发明人：WANG PENG; LI PIXU; WEI QIANG; LIU YUANHUA
权利人:SUZHOU PENGXU PHARMATECH CO LTD
摘要:The present invention provides a scalable synthesis of enantiomerically pure brivaracetam, and related derivatives.

专利号:EP-2520573-A1
优先权日:2011-05-06
标 题:Compounds with matrix-metalloproteinase inhibitory activity
发明人：HAUFE GUENTER; BEHRENDS MALTE; KOPKA KLAUS; WAGNER STEFAN; HUGENBERG VERENA; BREYHOLZ HANS-JOERG; HERMANN SVEN; SCHAEFERS MICHAEL; KOLB HARTMUTH
权利人:UNIV MUENSTER WILHELMS; SIEMENS MEDICAL SOLUTIONS
摘要:The present invention relates to the field of therapeutic and diagnostic agents and more specifically to compounds of formula (I) that are inhibitors of matrix-metalloproteinases (MMPs) and are useful in the treatment of diseases related thereto such as cardiovascular diseases, inflammatory diseases and malignant diseases. One embodiment of the invention is a compound of formula (I) labeled with a 18-fluorine atom having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the inhibitors of matrix-metalloproteinases (MMPs) of the invention or the corresponding labeled compounds useful as diagnostic imaging agents of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the inhibitors of matrix-metalloproteinases (MMPs) of the invention and of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention.

专利号:JP-2001503782-A
优先权日:1996-11-22
标题 :Method and compound for inhibiting release of beta-amyloid peptide and / or its synthesis

专利号:CN-102558012-B
优先权日:2012-03-15
标题:Synthesis method of levetiracetam

专利号:CN-115557873-A
优先权日:2022-10-19
标 题:A kind of synthesis method of buvaracetam methyl esterification impurity